BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Xtrana, Inc. (XTRN) And Alpha Innotech Corporation Announce Merger Agreement; Xtrana Accelerates Termination Of Shareholder Rights Plan


10/19/2005 5:12:28 PM

BROOMFIELD, Colo.--(BUSINESS WIRE)--Dec. 14, 2004--XTRANA, Inc. (OTCBB:XTRN) and Alpha Innotech Corporation announced today that they have entered into a definitive Agreement and Plan of Merger pursuant to which Alpha Innotech will merge with a wholly-owned subsidiary of Xtrana in a reverse merger transaction. Security holders of Alpha Innotech will receive shares of Xtrana common stock, and all outstanding Alpha Innotech stock options and warrants will be converted into options and warrants to purchase Xtrana common stock. Immediately following the consummation of the transaction, the stockholders of Xtrana will own approximately 17%, and the shareholders of Alpha Innotech will own approximately 83%, of the outstanding shares of common stock of the combined company. Pursuant to the definitive agreement, Xtrana also agreed to loan Alpha Innotech Corporation $500,000, with funding of the loan subject to fulfillment of specified conditions. Upon completion of the transaction, Xtrana is expected to change its corporate name to Alpha Innotech Corp.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES